Will Compass report or disclose cumulative synergy realization exceeding $100M within the first 12 months post-merger close?

The resolution criteria explicitly state 'discloses cumulative realized cost synergies (or run-rate annualized synergies).' The parenthetical 'or run-rate annualized' is the key clause. Management has already disclosed $175M in 'actioned' synergies at 6.5 weeks post-close, which on a run-rate annualized basis exceeds $100M by 75%. Even if 'actioned' is not strictly 'run-rate annualized,' the trajectory — $175M actioned in 6.5 weeks, CEO raising target to $250M — virtually guarantees that by Jan 9, 2027, management will have disclosed run-rate annualized synergies well above $100M. The only NO scenario requires management to deliberately obscure synergy progress, which contradicts their incentive to showcase integration success and justify the deal price.

Parsing the distinction between 'actioned' and 'run-rate annualized' more carefully: 'actioned' means decisions made (e.g., headcount reduction notices sent, facility lease terminations initiated). 'Run-rate annualized' means the annualized savings rate from actions already flowing through financials. At 6.5 weeks, the $175M actioned has likely only produced ~$5-15M in actual run-rate savings (management guided ~$5M in Q1 realization). However, the resolution window extends to Jan 9, 2027 — 12 months post-close. By then, the cumulative realized synergies are guided at ~$100M (the ramp: $5M Q1, building to $44M Q4), and the run-rate annualized will be much higher as later-quarter actions are annualized. The $100M cumulative realized alone appears achievable given the ramp guidance, and run-rate annualized will be significantly higher.

The risk decomposition now heavily favors YES. Execution risk (can they achieve $100M?): substantially de-risked by $175M actioned in 6.5 weeks and CEO raising target. Disclosure risk (will they report it?): CEO has personally committed to $300M and raised targets publicly — non-disclosure would be a credibility disaster. Definitional risk (does 'actioned' count as 'run-rate annualized'?): even if not, the realization ramp guided at ~$100M cumulative and the run-rate annualized from Q4 actions alone ($44M/quarter annualized = $176M) would easily clear. The residual NO probability (15%) accounts for: integration reversal (agents defect, costs increase), housing market crash forcing management to pause integration, or an extraordinary event that prevents synergy realization despite having been 'actioned.'

The arithmetic is straightforward post-earnings. Management guided ~$100M cumulative realized synergies in 2026, with the ramp building from $5M in Q1 to $44M in Q4. The resolution criteria accept 'run-rate annualized,' which will be higher than cumulative realized. By Q3 or Q4 2026, the quarterly run-rate alone annualized should comfortably exceed $100M. CEO raising the target to $250M from $150M is a strong confidence signal — management teams rarely raise targets unless they have high visibility into the cost reduction pipeline. The prior prediction of 55% reflected genuine uncertainty about execution at unprecedented scale; that uncertainty has been substantially resolved by 6.5 weeks of demonstrated action.

Slightly more cautious than other runs. While the $175M actioned figure is impressive, 'actioned' can include announcements and plans that may not fully materialize. Cost-to-achieve may consume up to 50% of gross synergies in the near term, meaning the $100M realized estimate could be $80-90M net after restructuring charges. Under strict 'realized' interpretation, this would miss the threshold. The 'run-rate annualized' clause rescues this scenario — even $80M in cumulative realized implies a run-rate well above $100M annualized. The key risk is that housing market deterioration forces management to slow integration and retain costs longer than planned, pushing realization below the ramp trajectory. I assign 22% to this combined risk scenario.

The prior prediction (55%) reflected genuine uncertainty about whether Compass could execute synergies at unprecedented scale. The Q4 earnings data resolves much of that uncertainty. $175M actioned in 6.5 weeks demonstrates the organization can identify and initiate cost reductions rapidly. The CEO raising the target to $250M is not just a confidence signal — it creates a public accountability mechanism that makes non-disclosure of synergy progress very costly reputationally. The run-rate annualized clause provides a safety net even if cumulative realization lags. The remaining 20% NO probability covers: (1) integration costs exceeding synergy gains, (2) agent defection creating revenue headwinds that offset cost savings, (3) management changing synergy reporting methodology to obscure progress.

$175M actioned in 6.5 weeks. CEO raised target to $250M. Resolution criteria say 'run-rate annualized' counts. The math is clear: even the guided ~$100M cumulative realized matches the threshold, and run-rate annualized will be higher. This is a strong YES now. The prior 55% was based on pre-earnings uncertainty that has been resolved.

The most recent data is overwhelming. $175M actioned in 6.5 weeks is the headline number. Even with 50% cost-to-achieve drag, the run-rate annualized from later quarters will exceed $100M. CEO raised target from $150M to $250M. The only risk is a major macro shock or integration reversal. Assigning 80% YES.

Strong YES. The data progression is compelling: pre-earnings uncertainty (55%) has been replaced by concrete evidence of rapid synergy action. The resolution criteria's 'run-rate annualized' clause is the key enabler — it means management can cite annualized savings from actions taken, not just cash realized. By Q3/Q4 2026, the quarterly realization rate annualized will be well above $100M. CEO's raised target to $250M signals internal confidence. Risk factors (integration reversal, housing crash) are tail scenarios at this point.